Status:
COMPLETED
Evaluation of Anterior Quadratus Lumborum Block for Postoperative Analgesia in Hip Arthroscopy
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Hip Disease
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Hip arthroscopy is performed frequently and the postoperative course often involves moderate to severe pain. There remains no definitive perioperative pain regimen that has been proven to be effective...
Eligibility Criteria
Inclusion
- Patients scheduled for hip arthroscopy
- Ability to follow study protocol
- English Speaking
Exclusion
- Hepatic or renal insufficiency
- Younger than 18 years old and older than 80
- Allergy or intolerance to one of the study medications
- Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
- Chronic opioid use (daily opioids use for longer than 3 months)
- Patients contraindicated to undergo a spinal anesthetic
- Non English Speakers
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2021
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT03432650
Start Date
June 1 2018
End Date
September 9 2021
Last Update
August 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of Special Surgery
New York, New York, United States, 10021